[Design of oligonucleotide inhibitors of the human DNA-methyltransferase 1]

Insights

Researchers designed novel oligonucleotide inhibitors targeting DNA methyltransferase 1 (Dnmt1), crucial for cell division and implicated in cancer. These modified DNA structures show enhanced affinity and potent inhibition of Dnmt1 activity in vitro.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Medicinal Chemistry

Background:

  • DNA methyltransferase 1 (Dnmt1) is essential for maintaining DNA methylation patterns during cell division.
  • Dnmt1's role in carcinogenesis has spurred interest in developing specific enzyme inhibitors.
  • Targeting Dnmt1 is a promising strategy for cancer therapy.

Purpose of the Study:

  • To design and synthesize novel oligonucleotide inhibitors targeting human Dnmt1.
  • To investigate the structure-activity relationships of various DNA modifications on Dnmt1 inhibition.
  • To evaluate the inhibitory potential of designed oligonucleotides against Dnmt1.

Main Methods:

  • Construction of single-, double-stranded, and hairpin DNA structures with modified recognition sites (5'-CG).
  • Incorporation of structural features like C:A-mismatch, phosphorothioate linkages, and modified bases (5,6-dihydro-5-azacytosine, etc.).
  • In vitro assays to determine the inhibitory concentration (IC50) against Dnmt1 using poly(dI-dC)·poly(dI-dC) as a substrate.

Main Results:

  • Oligonucleotides incorporating C:A-mismatch, phosphorothioates, and hairpin structures demonstrated increased affinity for Dnmt1.
  • Substitution of cytosine with modified bases further enhanced the inhibitory properties of the oligonucleotides.
  • The most effective oligonucleotide inhibitors achieved 50% inhibition at approximately 10(-7) M concentrations.

Conclusions:

  • Structural modifications significantly enhance the efficacy of oligonucleotide inhibitors against Dnmt1.
  • Designed oligonucleotide inhibitors exhibit superior in vitro activity compared to known Dnmt1 inhibitors.
  • These findings provide a foundation for developing potent Dnmt1-targeting therapeutics.

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
DNA Topoisomerases02:02

DNA Topoisomerases

Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types.  Type I...